Cargando…

Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients

INTRODUCTION: The natural history of consolidation on computed tomography (CT) rarely includes invasive cancers, and evidence of the ideal timing for surgical intervention via long-term follow-up studies remains unknown. METHODS: Between January 2012 and June 2017, pulmonary resection was undertaken...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroda, Hiroaki, Sugita, Yusuke, Ohya, Yuko, Yoshida, Tatsuya, Arimura, Takaaki, Sakakura, Noriaki, Hida, Toyoaki, Yatabe, Yasushi, Sakao, Yukinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305139/
https://www.ncbi.nlm.nih.gov/pubmed/30588114
http://dx.doi.org/10.2147/CMAR.S180757
_version_ 1783382498275753984
author Kuroda, Hiroaki
Sugita, Yusuke
Ohya, Yuko
Yoshida, Tatsuya
Arimura, Takaaki
Sakakura, Noriaki
Hida, Toyoaki
Yatabe, Yasushi
Sakao, Yukinori
author_facet Kuroda, Hiroaki
Sugita, Yusuke
Ohya, Yuko
Yoshida, Tatsuya
Arimura, Takaaki
Sakakura, Noriaki
Hida, Toyoaki
Yatabe, Yasushi
Sakao, Yukinori
author_sort Kuroda, Hiroaki
collection PubMed
description INTRODUCTION: The natural history of consolidation on computed tomography (CT) rarely includes invasive cancers, and evidence of the ideal timing for surgical intervention via long-term follow-up studies remains unknown. METHODS: Between January 2012 and June 2017, pulmonary resection was undertaken in 293 clinical IA patients who were followed-up for > 6 months after the first detection of potential non-small-cell lung cancer (NSCLC) opacities. We evaluated the corresponding HRs and compared the recurrence risk with the CT follow-up duration. RESULTS: HRs calculated for the longest intervals were compared between two patient subsets: a shorter-interval surgery group (SISG: 41.3%; mean follow-up interval, 13.5±5.3 months) and a longer-interval surgery group (58.7%; mean follow-up interval, 54.9±25.6 months). On Cox multivariate regression analyses, CT consolidation (ratio >0.5), an abnormal carcinoembryonic antigen and a triple-negative mutation showed an independent association with an unfavorable prognosis, as measured by disease-free survival after the first detection of potential NSCLC opacities. The longer-interval surgery group fared significantly better than the SISG in terms of 5-year overall survival after the first detection (99.3% vs 93.1%, P<0.01); the 3-year overall survival after the first detection was significantly shorter in the high-risk SISG (presence of two factors from the three) than that in the low-risk SISG (presence of 0 or one factor; 100% vs 73.3%, P<0.01). CONCLUSION: Our study indicates that the patients with potential NSCLC opacities who are able to wait for more than 2 years prior to pulmonary resection may be likely to have a favorable prognosis, whereas early judgment for surgical resection should be required for avoiding surgical delays.
format Online
Article
Text
id pubmed-6305139
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63051392018-12-26 Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients Kuroda, Hiroaki Sugita, Yusuke Ohya, Yuko Yoshida, Tatsuya Arimura, Takaaki Sakakura, Noriaki Hida, Toyoaki Yatabe, Yasushi Sakao, Yukinori Cancer Manag Res Original Research INTRODUCTION: The natural history of consolidation on computed tomography (CT) rarely includes invasive cancers, and evidence of the ideal timing for surgical intervention via long-term follow-up studies remains unknown. METHODS: Between January 2012 and June 2017, pulmonary resection was undertaken in 293 clinical IA patients who were followed-up for > 6 months after the first detection of potential non-small-cell lung cancer (NSCLC) opacities. We evaluated the corresponding HRs and compared the recurrence risk with the CT follow-up duration. RESULTS: HRs calculated for the longest intervals were compared between two patient subsets: a shorter-interval surgery group (SISG: 41.3%; mean follow-up interval, 13.5±5.3 months) and a longer-interval surgery group (58.7%; mean follow-up interval, 54.9±25.6 months). On Cox multivariate regression analyses, CT consolidation (ratio >0.5), an abnormal carcinoembryonic antigen and a triple-negative mutation showed an independent association with an unfavorable prognosis, as measured by disease-free survival after the first detection of potential NSCLC opacities. The longer-interval surgery group fared significantly better than the SISG in terms of 5-year overall survival after the first detection (99.3% vs 93.1%, P<0.01); the 3-year overall survival after the first detection was significantly shorter in the high-risk SISG (presence of two factors from the three) than that in the low-risk SISG (presence of 0 or one factor; 100% vs 73.3%, P<0.01). CONCLUSION: Our study indicates that the patients with potential NSCLC opacities who are able to wait for more than 2 years prior to pulmonary resection may be likely to have a favorable prognosis, whereas early judgment for surgical resection should be required for avoiding surgical delays. Dove Medical Press 2018-12-20 /pmc/articles/PMC6305139/ /pubmed/30588114 http://dx.doi.org/10.2147/CMAR.S180757 Text en © 2019 Kuroda et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kuroda, Hiroaki
Sugita, Yusuke
Ohya, Yuko
Yoshida, Tatsuya
Arimura, Takaaki
Sakakura, Noriaki
Hida, Toyoaki
Yatabe, Yasushi
Sakao, Yukinori
Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
title Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
title_full Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
title_fullStr Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
title_full_unstemmed Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
title_short Importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage IA patients
title_sort importance of avoiding surgery delays after initial discovery of suspected non-small-cell lung cancer in clinical stage ia patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305139/
https://www.ncbi.nlm.nih.gov/pubmed/30588114
http://dx.doi.org/10.2147/CMAR.S180757
work_keys_str_mv AT kurodahiroaki importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT sugitayusuke importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT ohyayuko importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT yoshidatatsuya importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT arimuratakaaki importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT sakakuranoriaki importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT hidatoyoaki importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT yatabeyasushi importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients
AT sakaoyukinori importanceofavoidingsurgerydelaysafterinitialdiscoveryofsuspectednonsmallcelllungcancerinclinicalstageiapatients